|
Mr. Mow has served as our Vice President, Business Development since March 2007. Prior to joining Amylin, Mr. Mow was Co-founder, Vice President, Commercial and Business Development, and Secretary of Corus Pharma, Inc. until their acquisition by Gilead Sciences in 2006. From 1997 to 2000, Mr. Mow led the Business Development efforts for PathoGenesis Corporation, culminating with the company’s acquisition by Chiron Corporation in 2000. From 1995 to 1997, he was Associate Director, Worldwide Oncology Marketing and Strategic Business Planning at Bristol Myers-Squibb. Earlier Mr. Mow held various positions in Marketing and Sales at Wyeth/Lederle International and Syntex Laboratories. He also serves as a board member for AerovectRx Corporation. Mr. Mow received his B.S. in Mechanical Engineering from the University of California, Berkeley and his M.B.A. from the Tepper School of Management at Carnegie Mellon University. | 